The rise and fall of primary hyperparathyroidism: A population-based study in Rochester, Minnesota, 1965-1992

Annals of Internal Medicine

Volumn 126, Issue 6, 1997, Pages 433-440

  Wermers, Robert A ^b   Khosla, Sundeep ^a   Atkinson, Elizabeth J ^a   Hodgson, Stephen F ^a   O'Fallon, W Michael ^a   Melton III, L Joseph ^a  

^a MAYO CLINIC   (United States)

^b Wedgewood Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCALCEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; UNITED STATES;

EID: 0031042661     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-6-199703150-00003     Document Type: Article

References (65)

1. Esselstyn CB Jr, Crue G Jr. Hyperparathyroidism - epidemic or endemic? Diagnosis and treatment. Cleve Clin Q. 1970;37:87-91.
2. Haff RC, Black WC, Ballinger WF. Primary hyperparathyroidism: changing clinical, surgical and pathologic aspects. Ann Surg. 1970;171:85-92.
3. Mays ET, Weakley SD. Serum multichannel autoanalyzers in the detection of hypercalcemia and hyperparathyroidism. Surg Gynecol Obstet. 1971;133:603-8.
4. Preisman RA, Mehnert JH. A plethora of primary hyperparathyroidism. Arch Surg. 1971;103:12-3.
5. Johansson H, Thoren L, Werner I. Hyperparathyroidism. Clinical experiences from 208 cases. Ups J Med Sci. 1972;77:41-6.
6. Heath H 3d, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;302:189-93.
7. Stenstrom G, Heedman PA. Clinical findings in patients with hypercalcaemia. A final investigation based on biochemical screening. Acta Med Scand. 1974;195:473-7.
8. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980;1:1317-20.
9. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245:54-63.
10. Melton LJ 3d. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-74.
11. Kao PC, van Heerden JA, Grant CS, Klee GG, Khosla S. Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc. 1992;67:637-45.
12. Arnaud CD, Tsao HS, Littledike T. Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest. 1971;50:21-34.
13. Kao PC, Jiang NS, Klee GG, Purnell DC. Development and validation of a new radioimmunoassay for parathyrin (PTH). Clin Chem. 1982;28:69-74.
14. Law WM Jr, Heath H 3d. Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med. 1985;102:511-9.
15. Heath H 3d. Familial benign (hypocalciuric) hypercalcemia. A troublesome mimic of mild primary hyperparathyroidism. Endocrinol Metab Clin North Am. 1989;18:723-40.
16. Bergstralh EJ, Offord KP, Chu CP, Beard CM, O'Fallon WM, Melton LJ 3d. Calculating incidence, prevalence and mortality rates for Olmsted County, Minnesota: an update. Technical Report Series no. 49, Rochester, MN: Mayo Clinic; 1992
17. Aitken RE, Bartley PC, Bryant SJ. Lloyd HM. The effect of multiphasic biochemical screening on the diagnosis of primary hyperparathyroidism. Aust N Z J Med. 1975;5:224-6.
18. Trigonis C, Hamberger B, Farnebo LO, Abarca J, Granberg PO. Primary hyperparathyroidism. Changing trends over fifty years. Acta Chir Scand. 1983;149:675-9.
19. Palmer M, Ljunghall S, Akerström G, Adami HO, Bergstrom R, Grimelius L, et al. Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings. J Chronic Dis. 1987;40:121-30.
20. Heath H 3d. Clinical spectrum of primary hyperparathyroidisrn: evolution with changes in medical practice and Technology. J Bone Miner Res. 1991, 6(Suppl 2):S63-70.
21. Dent DM, Miller JL, Klaff L, Barron J. The incidence and causes of hypercalcaemia. Postgrad Med J. 1987;63:745-50.
22. Wérneau JL, Gilliot-Vattille E, Bizard JP, Leroy R, Marchandise X, Decoulx M, et al. Current concepts in primary hyperparathyroidisrn. Horm Res. 1989;32:93-6.
23. Boonstra CE, Jackson CE. Serum calcium survey for hyperparathyroidisrn: results in 50,000 clinic patients. Am J Clm Pathol. 1971;55:523-6.
24. Bates B, Yellin JA. The yield of multiphasic screening. JAMA. 1972;222:74-8.
25. Friedman GD, Goldberg M, Ahuja JN, Siegelaub AB, Bassis ML, Collen MI. Biochemical screening tests. Effect of panel size on medical care. Arch Intern Med. 1972;129:91-7.
26. Link K, Center R, Buchsbaum D, Witherspoon J. Why physicians don't pursue abnormal laboratory tests: an investigation of hypercalcemia and the follow-up of abnormal test results. Hum Pathol. 1984;15:75-8.
27. Waldenström JG. Systematic serum calcium screening - will it be necessary? Acta Med Scand. 1973;193:145-6.
28. Innes A, Catto GR, Reid I, Matheson NA. The infrequency of primary hyperparathyroidism in north-east Scotland. J R Coll Surg Edmb. 1987;32:263-6.
29. Mollerup CL, Bollerslev J, Blkhert-Toft M. Primary hyperparathyroidism: incidence and clinical and biochemical characteristics. A demographic study. Eur J Surg. 1994;160:485-9.
30. McGeown MG. Sex, age, and hyperparathyroidism. Lancet. 1969;1:887-8.
31. Muller H. Sex, age, and hyperparathyroidism. Lancet. 1969;1:449-50.
32. Kennedy DL, Baum C, Forbes MB. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol. 1985;65:441-6.
33. Hemminki E, Kennedy DL, Baum C, McKinlay SM. Prescribing of non-contraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health. 1988;78:1479-81.
34. Derby CA, Hume AL, Barbour MM, McPhillips JB, Lasater TM, Carleton RA. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol. 1993;137:1125-35.
35. Avis NE, McKinlay SM. Health-care utilization among mid-aged women. Ann N Y Acad Sci. 1990;592:228-38.
36. Scalley EK, Henrich JB. An overview of estrogen replacement therapy in postmenopausal women. Journal of Women's Health. 1993;2:289-94.
37. Wiske PS, Epstein S, Bell NH, Queener SF, Edmonson J, Johnston CC. Increases in immunoreactive parathyroid hormone with age. N Engl J Med. 1979;300:1419-21.
38. Marcus R, Madvig P, Young G. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. J Clin Endocrinol Metab. 1984;58:223-30.
39. 3. J Clin Endocrinol Metab. 1994;79:211-6.
40. Ledger GA, Burritt MF, Kao PC, O'Fallon WM, Riggs BL, Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab. 1995;80:3304-10.
41. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, et al. Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure, and vitamin D. Calcif Tissue Int. 1995;56:104-8.
42. Prince RL, Dick I, Devine A, Price RI, Gutteridge DH, Kerr D, et al. The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90. J Bone Miner Res. 1995;10:835-42.
43. McKane WR, Khosla S, Egan KS, Robins SP, Burritt MF, Riggs BL. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption J Clin Endocrinol Metab 1996;81:1699-703.
44. Bullamore JR, Wilkinson R, Gallagher JC, Nordin BE, Marshall DH. Effect of age on calcium absorption. Lancet. 1970;2:535-7.
45. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest. 1979;64:729-36.
46. Heaney RP, Recker RR, Stegman MR, Moy AJ. Calcium absorption in women: relationships to calcium intake, estrogen status, and age. J Bone Miner Res. 1989;4:469-75.
47. Eastell R, Calvo MS, Burritt MF, Offord KP, Russell RG, Riggs BL. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J Clin Endocrinol Metab. 1992;74:487-94.
48. Nordin BE, Horowitz M, Need A, Morris HA. Renal leak of calcium in post-rnenopausal osteoporosis. Clin Endocrinol. 1994;41:41-5.
49. Heaney RP. Editorial: Calcium, parathyroid function, bone and aging. J Clin Endocrinol Metab. 1996;81:1697-8
50. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drueke TB. Monoclonahty of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest. 1995;95:2047-53.
51. Fujiwara S, Sposto R, Ezaki H, Akiba S, Neriishi K, Kodama K, et al. Hyperparathyroidism among atomic bomb survivors in Hiroshima. Radiat Res. 1992;130:372-8.
52. Tisell LE, Carlsson S, Fjalling M, Hansson G, Lindberg S, Lundberg LM, et al. Hyperparathyroidism subsequent to neck irradiation. Risk factors. Cancer. 1985;56:1529-33.
53. Schneider AB, Gierlowski T, Shore-Freedman E, Stovall M, Ron E, Lubin J. Dose-response relationships for radiation-induced hyperparathyroidism. J Clin Endocrinol Metab. 1995;80:254-7.
54. Beard CM, Heath H 3d, O'Fallon WM, Anderson JA, Earle JD, Melton LJ 3d. Therapeutic radiation and hyperparathyroidism: a case-control study in Rochester, Mmn. Arch Intern Med. 1989;149:1887-90.
55. Tisell LE, Carlsson S, Lindberg S, Ragnhult I. Autonomous hyperparathyroidism: a possible late complication of neck radiotherapy. Acta Chir Scand. 1976;142:367-73.
56. Tisell LE, Hansson G, Lindberg S, Ragnhult I. Hyperparathyroidism in persons treated with x-rays for tuberculous cervical adenitis. Cancer. 1977;40:846-54.
57. Prinz RA, Paloyan E, Lawrence AM, Pickleman JR, Braithwaite S, Brooks MH. Radiation-associated hyperparathyroidism: a new syndrome? Surgery. 1977;82:296-302.
58. Russ JE, Scanion EF, Sener SF. Parathyroid adenomas following irradiation. Cancer. 1979;43:1078-83.
59. Nishiyama RH, Farhi D, Thompson NW. Radiation exposure and the simultaneous occurrence of primary hyperparathyroidism and thyroid nodules, Surg Clin North Am. 1979;59:65-75.
60. Rao SD, Frame B, Miller MJ, Kleerekoper M, Block MA, Parfitt AM. Hyperparathyroidism following head and neck irradiation. Arch Intern Med. 1980;140:205-7.
61. Hedman I, Hansson G, Lundberg LM, Tisell LE. A clinical evaluation of radiation-induced hyperparathyroidism based on 148 surgically treated patients. World J Surg. 1984;8:96-105.
62. Christmas TJ, Chapple CR, Noble JG, Milroy EJ, Cowie AG. Hyperparathyroidism after neck irradiation. Br J Surg. 1988;75:873-4.
63. De Jong SA, Demeter JG, Jarosz H, Lawrence AM, Paloyan E. Thyroid carcinoma and hyperparathyroidism after radiation therapy for adolescent acne vulgaris. Surgery. 1991;110:691-5.
64. Favus MJ, Schneider AB, Stachura ME, Arnold JE, Ryo UY, Pinsky SM, et al. Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients. N Engl J Med. 1976;294:1019-25.
65. Modan B, Ron E, Werner A. Thyroid cancer following scalp irradiation. Radiology. 1977;123:741-4.